Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect
Autor: | Peña-Bautista C, Roca, M, López-Cuevas R, Baquero M, Vento M, Cháfer-Pericás C |
---|---|
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname |
ISSN: | 0731-7085 |
Popis: | Alzheimer Disease (AD) is the main cause of dementia, and it has a great social and economic impact worldwide. It is a complex multifactorial disease, and we still do not know enough about its causes. For this reason, omics studies could be a useful tool for the search for new biomarkers and for enhancing the knowledge of different metabolic pathways that may be altered in the initial stages of the disease. Metabolomic analysis was carried out for plasma samples from early AD patients and healthy controls. Obtained data were normalized and analyzed by volcano plot and supervised orthogonal-least-squares-discriminant analysis. Fifteen variables were selected as the most important variables for the groups' discrimination, and the different levels of 6 identified metabolites could discriminate between patients with different ApoE4 genotypes (e4-carriers and non e4-carriers). In conclusion, ApoE4 genotype is associated with changes in lipid metabolomics profile in AD patients, and it could be relevant for the development of AD since early stages. |
Databáze: | OpenAIRE |
Externí odkaz: |